which regulates neutrophil proliferation and differentiation (13). The CDNAencoding hG-CSF was cloned (15, 19) and large scale production of the recombinant human G-CSF (rhG-CSF) was obtained using genetically engineered Escherichia coli (19) . rhG-CSF is also capable of supporting the formation of granulocytic colonies from bone marrowcells and is undergoing clinical testing for cancer patients with drug-or irradiation-induced myelosuppression (14, 22) . rhG-CSFhas one free cysteine at position 17 and has two disulfide bridges (Cys36-Cys42 and Cys64-Cys74) (9). It is known that the free cysteines in T4 Lysozyme (16) , Interferon-/3 (ll) and Interleukin-2 (IL-2) (2) are involved in intermolecular thiol/disulfide interchange leading to inactive oligomers. Mutagenic replacement of unpaired Cys54 of T4 Lysozyme with Thr or Val generated one exhibiting enhanced stability toward irreversible thermal inactivation. In the case of IL-2, substitution of Cysl25 with Ser or Ala yielded one with greater stability.
In the case of rhG-CSF, previous studies
showed that the substitution of unpaired Cysl7 of rhG-CSF with Ser did not change its conformational stability (23) and that the 17th residue of murine G-CSF was serine (18).
In this report, we substituted the unpaired Cysl7 of rhG-CSF with several other amino acids or deleted and f To whomcorrespondence should be addressed. Abbreviations: G-CSF, granulocyte-colony stimulating factor; CD, circular dichroism. compared their stabilities.
Amongthose mutant proteins, Alal7-rhG-CSF was found to have more than 5 times greater stability than rhG-CSF.
MATERIALS AND METHODS
Materials. E. coli DNApolymerase I Klenow fragment, T4 polynucleotide kinase, T4 DNApolymerase, T4 DNAligase, T4 gene 32 protein and restriction enzymes were purchased from Boehringer Mannheim, Takara Shuzo or BioRad. Bacteriophage M13mpl9 (24) was obtained from Takara Shuzo.
Recombinant DNAmethods. Recombinant DNAmethods were performed as described by Manniatis et al. (10) . Synthesis of oligonucleotide. Oligonucleotides were prepared by the phosphoramidite method (3) using a DNAsynthesizer (Applied Biosystems). Site-directed mutagenesis of human G-CSFgene. An hG-CSF expression plasmid, pCFM1156 hG-CSF, containing a chemically synthesized G-CSF gene (20) , was digested with Xbal and EcoRl. The smaller Xbal-EcoRI fragment was inserted between the Xbal and EcoRI sites of bacteriophage M13mpl9. The resulting Ml3 bacteriophage contains the hG-CSF gene. Site-directed mutagenesis of hG-CSF gene using an oligonucleotide was performed as described by Zoller et al. (25) or Kunkel et al. (7) . The nucleotide sequence of the mutated hG-CSF genes were confirmed by the dideoxy sequencing method (12). To insert the mutated hG-CSF genes into the expression plasmid, an.EcoRI site located at the 3' end of human G-CSF gene was changed to Xhol site by site-directed mutagenesis. The resulting Ml3 bacteriophages containing the mutated hG-CSFgenes were digested with Xbal and Xhol. The small Xbal and Xhol fragments containing the mutated hG-CSF genes were ligated with the large Xbal-Xhol fragment of the hG-CSFexpression plasmid, pCFM536 (19) . Production and purification of rhG-CSF mutant proteins. Expression of the mutated human G-CSFgenes in E. coli and purification of mutant proteins of rhG-CSF were performed as previously described (21). Biological activity. Biological activities of rhG-CSF mutant proteins were measured by the uptake of [3H]-thymidine into mousebone marrowcells following the procedure of Ralph et al. (17) with some modifications. In brief, low-density (< 1.077 g/cm~3) nonadherent bone marrow cells from female Balb/c mice were incubated for 3 days in dilutions of rhG-CSF mutant proteins in supplemented McCoy's 5a medium (10% fetal calf serum). The cell concentration was 8 x 104 cells per well in a volume of 0.2ml in 96 well flat-bottom plates. After the incubation, the cells were pulse-labelled with 3H-thymidine for 5 hours (1 //Ci per well), harvested on glass fiber filters and assayed for radioactivity using a liquid-scintillation counter. Biological activities of rhG-CSF mutant proteins were calculated by a parallel line assay. A purified preparation of rhG-CSF, quantified by the mouse bone marrowcolony assay, was used as a standard. Aminoacid sequence analysis. The N-terminal sequences of rhG-CSF and its mutant proteins were determined using a gas-phase sequencer (Applied Biosystems model 470A) follow- . Circular dichroic (CD) spectrometry. The CD spectra of the proteins were measured with a Jasco J600 spectropolarimeter. Spectra were recorded at 15°C using a 0.1 cm-path-length cell with 1 nm band-width. Measurements were carried out using approximately 0.5 mg/ml at pH 4.0. The spectral data were expressed as molar ellipticity ([#]mrw), calculated using a mean residue weight of 104.4 (5) . Gel filtration HPLCanalysis. The quantitative measurements of monomercontents of rhG-CSFmutant proteins were carried out by gel nitration analysis using a HPLCchromatography system. The column was a TSKgel-G3000SW (7.5mmx60cm).
The solvent, used at a flow rate of 1.0 ml/min, was 10 mMSodium acetate buffer (pH 5.4). Absorbance at 280 nm was used for the detection of proteins.
Other methods. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out as described by Laemmli (8) using 15%polyacrylamide gels. Coomassie brilliant blue R-250 was used to stain the protein bands. Protein concentration was spectrophotometrically determined by absorbance at 280nm.
RESULTS AND DISCUSSION
Preparation ofrhG-CSF mutantproteins. The cysteine situated at position 17 of the chemically synthesized hG-CSF gene was replaced by Gly, Ala, Ser, He, Tyr, Arg and Pro, or deleted by site-directed mutagenesis using an oligonucleotide.
The mutated hG-CSF genes were expressed in E. coli. The mutant rhG-CSF proteins were extracted from E. coli cells and purified to homogeneity except Prol7-rhG-CSF. Prol7-rhG-CSF could be expressed in the cells, but could not be completely purified because it formed aggregation bodies during the purification process. The molecular weights of Prol7-rhG-CSF, they all retained biological activity in vitro. Glyl7-rhG-CSF, Alal7-rhG-CSF and Serl7-rhG-CSF had almost the same or higher specific biological activities than rhG-CSF, and the other mutants had lower activities. Prol7-rhG-CSF had no detectable biological activity. These results indicate that the amino acid residue at position 17 affects the biological activity in some degree but does not play an essential role. Thermostabilities of mutant proteins. To investigate the thermostabilities of mutant proteins, they were incubated at 53°C and their residual biological activities were assayed. Table I shows the results with regard to rhG-CSF, Alal7-rhG-CSF and Serl7-rhG-CSF. Other mutant proteins retained less than \% of their initial activities after 6 hr incubation. The enhanced thermostability of Alal7-rhG-CSF was further confirmed by gel filtration HPLCanalysis. The intermodular thiol/disulfide interchange caused the formation of oligomers of rhG-CSF. In our preliminary study, we found a linear correlation between the biological activity of rhG-CSF and the amount of its monomerform (data not shown). Hence, we incubated these mutant proteins at 53°C and measured their residual monomercontents (%) by gel filtration HPLCanalysis. Figure 2 shows the decrease of the residual monomercontent (%) of each mutant protein during the incubation at 53°C.
Wecalculated the half-life time of the residual monomer content (%) of each mutant protein from the data of Figure 2 . The half-life time of monomer content (%) of rhG-CSF or Serl7-rhG-CSF under these conditions was 34 hours and 50 hours, respectively. On the other hand, that of Alal7-rhG-CSF was more than 168 hours (Fig. 3) . These results show that the replacement of Cysl7 with Ala improved the heat-stability of rhG-CSF greatly and that not only the disulfide bond scrambling of Cysl7 but also other properties may be relevant to its heat-stability. As the CDspectra of mutant proteins except Prol7-rhG-CSF at far UV region (200-250 nm) were similar to that of rhG-CSF (Fig. 4) , it is thought that those mutant proteins had similar conformations.
But some conformational change of the side chain at the residue of position 17 may affect the heat-stability of rhG-CSF. More information about the structure of rhG-CSF, for instance x-ray diffraction data, will help to explain the relationship between the stability of rhG-CSF and the 17th amino acid residue in more detail. 
